Lupron and Large intestinal obstruction - a phase IV clinical study of FDA data
Summary:
Large intestinal obstruction is reported as a side effect among people who take Lupron (leuprolide acetate), especially for people who are male, 60+ old, also take Xtandi, and have Prostate cancer stage iv.
The phase IV clinical study analyzes which people have Large intestinal obstruction when taking Lupron. It is created by eHealthMe based on reports of 41,483 people who have side effects when taking Lupron from the FDA, and is updated regularly.
What is Lupron?
Lupron has active ingredients of leuprolide acetate. It is often used in endometriosis. eHealthMe is studying from 42,122 Lupron users. Check the latest studies of Lupron.
What is Large intestinal obstruction?
Large intestinal obstruction is found to be associated with 278 drugs and 367 conditions by eHealthMe. Check the latest studies of Large intestinal obstruction.
41,483 people reported to have side effects when taking Lupron.
Among them, 13 people (0.03%) have Large intestinal obstruction.

Among these 13 people:
What is the gender of people who have Large intestinal obstruction when taking Lupron? *
- female: 0.0 %
- male: 100 %
What is the age of people who have Large intestinal obstruction when taking Lupron? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
What are other drugs people take besides Lupron? *
- Xtandi: 6 people, 46.15%
- Zocor: 3 people, 23.08%
- Aspirin: 3 people, 23.08%
- Casodex: 3 people, 23.08%
- Lipitor: 3 people, 23.08%
- Hyzaar: 2 people, 15.38%
- Amlodipine: 2 people, 15.38%
- Bentyl: 2 people, 15.38%
- Taxotere: 2 people, 15.38%
- Celebrex: 2 people, 15.38%
What are other side effects people have besides Large intestinal obstruction? *
- Hot Flush (sudden feelings of heat): 7 people, 53.85%
- Abdominal Distension: 5 people, 38.46%
- Back Pain: 5 people, 38.46%
- Fatigue (feeling of tiredness): 5 people, 38.46%
- Gallstones (stone formation by bile component): 5 people, 38.46%
- Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 4 people, 30.77%
- Diverticulum Intestinal (a pouch that is attached to the first part of the small intestine): 4 people, 30.77%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 4 people, 30.77%
- Gynecomastia (enlargement of the gland tissue of the male breast): 4 people, 30.77%
- Weight Decreased: 4 people, 30.77%
What are the existing conditions these people have? *
- Prostate Cancer Stage Iv: 3 people, 23.08%
- Pain: 2 people, 15.38%
- Gastric Ulcer (stomach ulcer): 2 people, 15.38%
- Anaemia (lack of blood): 2 people, 15.38%
- Abdominal Pain: 2 people, 15.38%
- Prostate Cancer Recurrent: 1 person, 7.69%
- Prostate Cancer Metastatic: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Lupron and have Large intestinal obstruction?
- Check whether Large intestinal obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Lupron:
- Lupron (42,122 reports)
Large intestinal obstruction treatments and more:
- Large intestinal obstruction (2,371 reports)
How severe was Large intestinal obstruction and when was it recovered:
Expand to all the drugs that have ingredients of leuprolide acetate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lupron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Large intestinal obstruction:
- Large intestinal obstruction (278 drugs)
Browse all the conditions that are associated with Large intestinal obstruction:
- Large intestinal obstruction (367 conditions)
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Pong YH, Lu YC, Tsai VF, Huang PL, Hsieh JT, Chang HC, "Acute manic and psychotic symptoms following subcutaneous leuprolide acetate in a male patient without prior psychiatric history: A case report and literature review", Urological Science, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Lupron) and Lupron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Oxycontin cause Hyperparathyroidism Secondary? - 17 seconds ago
- Could Norvir cause Diabetic Ketoacidosis? - 27 seconds ago
- Could Avapro cause Pruritus Aggravated? - 36 seconds ago
- Could Topiramate cause Hepatic Encephalopathy? - 42 seconds ago
- Could Elidel cause Vulvovaginal Dryness? - 42 seconds ago
- Drug interactions of Vascepa and Calcium - 43 seconds ago
- Drug interactions of Pentamidine Isethionate and Depakene - 43 seconds ago
- Could Voltaren cause Localised Infection? - 44 seconds ago
- Could Tadalafil cause Emphysema? - 48 seconds ago
- Could Metoclopramide Hydrochloride cause Hypokalemia? - 55 seconds ago